Literature DB >> 35800355

MicroRNA-155 inhibition attenuates myocardial infarction-induced connexin 43 degradation in cardiomyocytes by reducing pro-inflammatory macrophage activation.

Hai-Tao Yang1, Li-Li Li2, Song-Nan Li3, Jin-Tao Wu1, Ke Chen1, Wei-Feng Song1, Guo-Bao Zhang1, Ji-Fang Ma1, Hai-Xia Fu1, Sheng Cao4, Chuan-Yu Gao1, Juan Hu1.   

Abstract

Background: Degradation of pro-inflammatory macrophage-mediated connexin 43 (Cx43) plays an important role in post-myocardial infarction (MI) arrhythmogenesis, microRNA (miR)-155 produced by macrophages has been shown to mediate post-MI effects. We hypothesized that miR-155 inhibition attenuated MI-induced Cx43 degradation by reducing pro-inflammatory macrophage activation.
Methods: MI was induced by permanent ligation of the left anterior descending coronary artery in male C57BL/6 mice. Lipopolysaccharide (LPS)-stimulated mice bone marrow-derived macrophages (BMDMs) and hypoxia-induced neonatal rat cardiomyocytes (NRCMs) were used in vitro models. qRT-PCR, Western-blot and immunofluorescence were used to analyze relevant indicators.
Results: The expression levels of miR-155, interleukin-1 beta (IL-1β), and matrix metalloproteinase (MMP)7 were higher in MI mice and LPS-treated BMDMs than in the sham/control groups, treatment with a miR-155 antagomir reversed these effects. Moreover, miR-155 inhibition reduced ventricular arrhythmias incidence and improved cardiac function in MI mice. Cx43 expression was decreased in MI mice and hypoxia-exposed NRCMs, and hypoxia-induced Cx43 degradation in NRCMs was reduced by application of conditioned medium from LPS-induced BMDMs treated with the miR-155 antagomir, but increased by conditioned medium from BMDMs treated with a miR-155 agomir. Importantly, NRCMs cultured in conditioned medium from LPS-induced BMDMs transfected with small interfering RNA against IL-1β and MMP7 showed decreased hypoxia-mediated Cx43 degradation, and this effect also was diminished by BMDM treatment with the miR-155 agomir. Additionally, siRNA-mediated suppressor of cytokine signaling 1 (SOCS1) knockdown in LPS-induced BMDMs promoted Cx43 degradation in hypoxia-exposed NRCMs, and the effect was reduced by the miR-155 inhibition. Conclusions: MiR-155 inhibition attenuated post-MI Cx43 degradation by reducing macrophage-mediated IL-1β and MMP7 expression through the SOCS1/nuclear factor-κB pathway. 2022 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Myocardial infarction (MI); connexin 43 (Cx43); microRNA-155 (miR-55); ventricular arrhythmias

Year:  2022        PMID: 35800355      PMCID: PMC9253173          DOI: 10.21037/cdt-21-743

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  54 in total

Review 1.  Macrophages in Tissue Repair, Regeneration, and Fibrosis.

Authors:  Thomas A Wynn; Kevin M Vannella
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

2.  Anti-inflammatory activities of Waltheria indica extracts by modulating expression of IL-1B, TNF-α, TNFRII and NF-κB in human macrophages.

Authors:  Rozalia Laczko; Andrew Chang; Lindsey Watanabe; Maria Petelo; Kimberly Kahaleua; Jon-Paul Bingham; Katalin Csiszar
Journal:  Inflammopharmacology       Date:  2019-11-04       Impact factor: 4.473

3.  Absence of Rgs5 prolongs cardiac repolarization and predisposes to ventricular tachyarrhythmia in mice.

Authors:  Mu Qin; He Huang; Teng Wang; He Hu; Yu Liu; Hong Cao; Hongliang Li; Congxin Huang
Journal:  J Mol Cell Cardiol       Date:  2012-10-16       Impact factor: 5.000

4.  Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability.

Authors:  Christophe Furman; Corinne Copin; Mejid Kandoussi; Robert Davidson; Martine Moreau; Fergus McTaggiart; M John Chapman; Jean-Charles Fruchart; Mustapha Rouis
Journal:  Atherosclerosis       Date:  2004-05       Impact factor: 5.162

5.  Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation.

Authors:  Nicole M De Jesus; Lianguo Wang; Anthony W Herren; Jingjing Wang; Fatemah Shenasa; Donald M Bers; Merry L Lindsey; Crystal M Ripplinger
Journal:  Heart Rhythm       Date:  2014-10-07       Impact factor: 6.343

6.  The transcardiac gradient of cardio-microRNAs in the failing heart.

Authors:  Francine Z Marques; Donna Vizi; Ouda Khammy; Justin A Mariani; David M Kaye
Journal:  Eur J Heart Fail       Date:  2016-04-12       Impact factor: 15.534

7.  RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.

Authors:  Huilong Yin; Xiang Zhang; Pengyuan Yang; Xiaofang Zhang; Yingran Peng; Da Li; Yanping Yu; Ye Wu; Yidi Wang; Jinbao Zhang; Xiaochen Ding; Xiangpeng Wang; Angang Yang; Rui Zhang
Journal:  Nat Commun       Date:  2021-03-02       Impact factor: 14.919

8.  Auxiliary trafficking subunit GJA1-20k protects connexin-43 from degradation and limits ventricular arrhythmias.

Authors:  Shaohua Xiao; Daisuke Shimura; Rachel Baum; Diana M Hernandez; Sosse Agvanian; Yoshiko Nagaoka; Makoto Katsumata; Paul D Lampe; Andre G Kleber; TingTing Hong; Robin M Shaw
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

9.  Aquaporin-1 Deficiency Protects Against Myocardial Infarction by Reducing Both Edema and Apoptosis in Mice.

Authors:  Lihua Li; Zhiyong Weng; Chenjuan Yao; Yuanlin Song; Tonghui Ma
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

10.  Cells of the adult human heart.

Authors:  Monika Litviňuková; Carlos Talavera-López; Henrike Maatz; Daniel Reichart; Catherine L Worth; Eric L Lindberg; Masatoshi Kanda; Krzysztof Polanski; Matthias Heinig; Michael Lee; Emily R Nadelmann; Kenny Roberts; Liz Tuck; Eirini S Fasouli; Daniel M DeLaughter; Barbara McDonough; Hiroko Wakimoto; Joshua M Gorham; Sara Samari; Krishnaa T Mahbubani; Kourosh Saeb-Parsy; Giannino Patone; Joseph J Boyle; Hongbo Zhang; Hao Zhang; Anissa Viveiros; Gavin Y Oudit; Omer Ali Bayraktar; J G Seidman; Christine E Seidman; Michela Noseda; Norbert Hubner; Sarah A Teichmann
Journal:  Nature       Date:  2020-09-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.